金活醫藥集團(01110.HK)採納2025年股份獎勵計劃
格隆匯4月14日丨金活醫藥集團(01110.HK)公告,由於2019年股份獎勵計劃預期將於2025年8月屆滿,董事會欣然宣佈,董事會已於2025年4月14日採納2025年股份獎勵計劃,並終止2019年股份獎勵計劃,以(其中包括)反映上市規則第十七章的最新變動及規定。
2021年購股權計劃已於2021年8月20日獲股東採納。根據2021年購股權計劃,董事獲授權向若幹合資格參與者(包括集團任何執行董事、非執行董事及獨立非執行董事、顧問及諮詢師)授出認購股份的購股權,作爲彼等對集團所作貢獻的激勵或回報。監於上市規則第十七章的修訂已於2023年1月1日生效,2021年購股權計劃的規則並未完全符合上市規則第十七章的規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.